Literature DB >> 10582096

Rinderpest: the disease and its impact on humans and animals.

T Barrett1, P B Rossiter.   

Abstract

Rinderpest is an ancient plague of cattle and other large ruminants, with descriptions of its effects dating back to Roman times. It is caused by a morbillivirus closely related to human measles virus. Although a very effective vaccine is available, it is heat labile, and logistical and financial problems hamper its delivery to the remote areas of Africa and Asia where enzootic foci remain. Periodic epizootics emerge from these foci and spread into neighboring areas, mainly as a result of uncontrolled livestock movement and trading. This is particularly true during wars or civil disturbances when normal veterinary controls do not operate. The disease continues to cause devastating economic losses in domestic livestock in areas of the world where it remains endemic.

Entities:  

Mesh:

Year:  1999        PMID: 10582096     DOI: 10.1016/s0065-3527(08)60344-9

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


  23 in total

1.  Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope.

Authors:  E P Walsh; M D Baron; L F Rennie; P Monaghan; J Anderson; T Barrett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Measles virus and rinderpest virus divergence dated to the sixth century BCE.

Authors:  Ariane Düx; Sebastian Lequime; Philippe Lemey; Sébastien Calvignac-Spencer; Livia Victoria Patrono; Bram Vrancken; Sengül Boral; Jan F Gogarten; Antonia Hilbig; David Horst; Kevin Merkel; Baptiste Prepoint; Sabine Santibanez; Jasmin Schlotterbeck; Marc A Suchard; Markus Ulrich; Navena Widulin; Annette Mankertz; Fabian H Leendertz; Kyle Harper; Thomas Schnalke
Journal:  Science       Date:  2020-06-19       Impact factor: 47.728

3.  Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins.

Authors:  Paulo H Verardi; Fatema H Aziz; Shabbir Ahmad; Leslie A Jones; Berhanu Beyene; Rosemary N Ngotho; Henry M Wamwayi; Mebratu G Yesus; Berhe G Egziabher; Tilahun D Yilma
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Global rinderpest eradication: lessons learned and why humans should celebrate too.

Authors:  David M Morens; Edward C Holmes; A Sally Davis; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2011-06-07       Impact factor: 5.226

5.  Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus.

Authors:  Veronika von Messling; Nicholas Svitek; Roberto Cattaneo
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Disease mortality in domesticated animals is predicted by host evolutionary relationships.

Authors:  Maxwell J Farrell; T Jonathan Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-29       Impact factor: 11.205

Review 7.  Measles vaccination: Threat from related veterinary viruses and need for continued vaccination post measles eradication.

Authors:  Sara Louise Cosby; Leanne Weir
Journal:  Hum Vaccin Immunother       Date:  2017-12-14       Impact factor: 3.452

8.  Competitive enzyme-linked immunosorbent assay based on monoclonal antibody and recombinant hemagglutinin for serosurveillance of rinderpest virus.

Authors:  G J Renukaradhya; K B Suresh; M Rajasekhar; M S Shaila
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

9.  Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors.

Authors:  H Tatsuo; N Ono; Y Yanagi
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

10.  Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system.

Authors:  Veronika von Messling; Dragana Milosevic; Roberto Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.